🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/11/2015 | 157,98 | 157,98 | 148,48 | 148,66 | -5,16% | 6,01% | 624.700 |
| 10/11/2015 | 157,45 | 157,63 | 152,93 | 156,75 | -0,26% | 2,99% | 870.800 |
| 09/11/2015 | 153,60 | 158,00 | 153,04 | 157,16 | +2,30% | 3,23% | 728.300 |
| 06/11/2015 | 153,94 | 153,94 | 149,42 | 153,62 | +1,03% | 2,94% | 568.600 |
| 05/11/2015 | 150,10 | 152,69 | 147,56 | 152,06 | +0,70% | 3,42% | 722.800 |
| 04/11/2015 | 154,25 | 154,50 | 149,04 | 151,00 | -1,05% | 3,54% | 963.100 |
| 03/11/2015 | 152,00 | 154,62 | 150,30 | 152,60 | -0,30% | 2,84% | 639.000 |
| 02/11/2015 | 147,36 | 153,63 | 147,36 | 153,06 | +4,39% | 4,25% | 886.000 |
| 30/10/2015 | 144,36 | 148,28 | 142,39 | 146,63 | +2,15% | 4,08% | 1.441.800 |
| 29/10/2015 | 138,47 | 143,70 | 137,72 | 143,55 | +4,67% | 4,32% | 1.019.400 |
| 28/10/2015 | 137,80 | 138,79 | 134,00 | 137,15 | +0,04% | 3,48% | 1.023.500 |
| 27/10/2015 | 139,09 | 142,98 | 134,27 | 137,10 | +8,78% | 6,26% | 1.914.700 |
| 26/10/2015 | 126,47 | 129,90 | 125,11 | 126,03 | -0,01% | 3,79% | 905.200 |
| 23/10/2015 | 120,36 | 126,46 | 119,75 | 126,04 | +5,41% | 5,57% | 853.000 |
| 22/10/2015 | 123,99 | 124,77 | 117,88 | 119,57 | -3,06% | 5,56% | 1.050.400 |
| 21/10/2015 | 124,49 | 125,68 | 121,05 | 123,35 | +0,36% | 3,72% | 1.251.100 |
| 20/10/2015 | 127,10 | 127,82 | 122,24 | 122,91 | -3,09% | 4,39% | 769.600 |
| 19/10/2015 | 127,65 | 128,87 | 123,63 | 126,83 | -1,38% | 4,10% | 774.300 |
| 16/10/2015 | 128,21 | 131,37 | 125,12 | 128,60 | +0,91% | 4,87% | 1.127.900 |
| 15/10/2015 | 123,53 | 127,79 | 122,35 | 127,44 | +3,37% | 4,40% | 1.147.200 |
| 14/10/2015 | 123,33 | 125,32 | 121,85 | 123,28 | +0,83% | 2,81% | 963.800 |
| 13/10/2015 | 122,71 | 125,39 | 122,05 | 122,26 | -0,67% | 2,72% | 597.200 |
| 12/10/2015 | 124,81 | 125,26 | 122,28 | 123,09 | -0,40% | 2,39% | 438.500 |
| 09/10/2015 | 125,03 | 126,07 | 122,65 | 123,59 | -1,35% | 2,74% | 590.800 |
| 08/10/2015 | 122,87 | 126,32 | 120,35 | 125,28 | +1,98% | 4,86% | 851.700 |
| 07/10/2015 | 125,50 | 126,40 | 119,80 | 122,85 | -1,94% | 5,26% | 1.343.100 |
| 06/10/2015 | 127,68 | 127,68 | 120,20 | 125,28 | -1,12% | 5,86% | 1.125.500 |
| 05/10/2015 | 131,57 | 133,46 | 126,04 | 126,70 | -3,21% | 5,64% | 1.126.100 |
| 02/10/2015 | 127,38 | 131,59 | 125,64 | 130,90 | +1,17% | 4,67% | 984.700 |
| 01/10/2015 | 132,02 | 132,42 | 127,42 | 129,38 | -1,42% | 3,79% | 1.063.900 |